Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M845Revenue $M24.1Net Margin (%)-110.3Z-Score11.9
Enterprise Value $M631EPS $-0.5Operating Margin %-110.7F-Score4
P/E(ttm))0Cash Flow Per Share $-0.6Pre-tax Margin (%)-110.3Higher ROA y-yN
Price/Book3.810-y EBITDA Growth Rate %-1.7Quick Ratio13.4Cash flow > EarningsY
Price/Sales26.35-y EBITDA Growth Rate %-1.9Current Ratio13.4Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-18.9Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-21.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M68.0ROI % (ttm)-33.3Gross Margin Increase y-yN

Gurus Latest Trades with SGMO

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SGMOJean-Marie Eveillard 2014-03-31 Reduce-0.02%$13.25 - $23.86
($19.12)
$ 12.43-35%Reduce -52.81%400,000
SGMOJean-Marie Eveillard 2013-09-30 Add0.01%$7.92 - $11.28
($9.95)
$ 12.4325%Add 99.73%847,550
SGMOJean-Marie Eveillard 2013-06-30 Add$7.31 - $10.65
($8.72)
$ 12.4342%Add 41.45%424,350
SGMOJean-Marie Eveillard 2013-03-31 Buy 0.01%$6.01 - $10.8
($8.89)
$ 12.4340%New holding, 300000 sh.300,000
SGMOJean-Marie Eveillard 2010-03-31 Sold Out $4.76 - $6.63
($5.63)
$ 12.43121%Sold Out0
SGMOJean-Marie Eveillard 2009-12-31 Buy $5.04 - $8.09
($5.87)
$ 12.43112%New holding, 470 sh.470
SGMOJean-Marie Eveillard 2009-09-30 Sold Out -0.01%$4.26 - $9.03
($6.32)
$ 12.4397%Sold Out0
SGMOJean-Marie Eveillard 2009-06-30 Buy 0.01%$3.51 - $4.98
($4.2)
$ 12.43196%New holding, 260600 sh.260,600
SGMOJean-Marie Eveillard 2009-03-31 Sold Out -0.01%$2.99 - $5.05
($4.1)
$ 12.43203%Sold Out0
SGMOJean-Marie Eveillard 2008-12-31 Buy 0.01%$2.13 - $7.81
($4.6)
$ 12.43170%New holding, 288000 sh.288,000
SGMOJean-Marie Eveillard 2008-06-30 Sold Out $9.07 - $13.37
($11.3)
$ 12.4310%Sold Out0
SGMOJean-Marie Eveillard 2007-12-31 Buy 0.01%$12.81 - $18.5
($15.1)
$ 12.43-18%New holding, 50000 sh.50,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SGMO is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
SGMO Jean-Marie Eveillard 2014-03-31400,0000.590.02-52.81%
Premium Most recent portfolio changes are included for Premium Members only!


SGMO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LANPHIER EDWARD O IIPresident & CEO 2014-07-18Sell25,000$12.162.22view
Wolff Henry WardExec VP & CFO 2014-07-10Sell15,000$13.26-6.26view
Gregory Philip DSVP of Research & CSO 2014-07-01Sell15,000$15.66-20.63view
Ramasastry SairaDirector 2014-06-23Sell5,550$15.53-19.96view
LANPHIER EDWARD O IIPresident & CEO 2014-06-16Sell25,000$16.41-24.25view
Wolff Henry WardExec VP & CFO 2014-06-10Sell15,000$15.62-20.42view
Mento Steven JDirector 2014-06-09Sell4,328$15-17.13view
Gregory Philip DSVP of Research & CSO 2014-06-02Sell15,000$12.85-3.27view
ANDO DALE GVP, Therapeutic Dev. & CMO 2014-05-27Sell15,000$13.57-8.4view
LANPHIER EDWARD O IIPresident & CEO 2014-05-15Sell25,000$13.14-5.4view

Press Releases about SGMO :

    Quarterly/Annual Reports about SGMO:

    News about SGMO:

    Articles On GuruFocus.com
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Nov 03 2010 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Aug 05 2010 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) May 05 2010 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Nov 06 2009 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Aug 03 2009 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) May 05 2009 
    Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results Feb 04 2009 

    More From Other Websites
    Nasdaq stocks posting largest percentage decreases Jul 29 2014
    SANGAMO BIOSCIENCES INC Files SEC form 10-Q, Quarterly Report Jul 29 2014
    Sangamo BioSciences Reports Second Quarter 2014 Financial Results Jul 23 2014
    SANGAMO BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 23 2014
    Sangamo BioSciences Reports Second Quarter 2014 Financial Results Jul 23 2014
    Q2 2014 Sangamo BioSciences Inc Earnings Release - After Market Close Jul 23 2014
    Sangamo BioSciences Announces Second Quarter 2014 Conference Call And Webcast Jul 16 2014
    Grading Sobek's Mid-Year Biotech Stock Predictions Jul 09 2014
    SANGAMO BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to... Jun 19 2014
    Sangamo BioSciences Appoints H. Stewart Parker to its Board of Directors Jun 19 2014
    Sangamo BioSciences Announces Presentation At The 2014 JMP Securities Healthcare Conference Jun 17 2014
    Will Sangamo (SGMO) Continue to Surge Higher? Jun 11 2014
    Sangamo BioSciences And City of Hope Granted Strategic Partnership Award From California Institute... May 30 2014
    Sangamo BioSciences Announces Presentation At The Jefferies 2014 Global Healthcare Conference May 29 2014
    Sangamo BioSciences Announces Publication of Preclinical Data Demonstrating Gene Correction in... May 28 2014
    Sangamo provies clinical update on SB-728-T program May 27 2014
    Sangamo BioSciences Provides Clinical Update on SB-728-T Program and Progress in Other ZFP... May 27 2014
    Sangamo BioSciences (SGMO) Presents at UBS Global Healthcare Conference (Transcript) May 21 2014
    American Society of Gene & Cell Therapy to hold annual meeting May 21 2014
    Sangamo BioSciences Announces Presentation At The UBS Global Healthcare Conference May 15 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide